|
April 11, 2008
Targeted Quality Improvement Support - Controlled Cardiac Surgery
Postoperative Blood Glucose
| TO: |
Chief Executive Officers |
| |
Critical Care Directors |
| |
Cardiothoracic Surgery Directors |
| |
Pharmacy Directors |
| |
Quality Directors |
| |
Infection Control Professionals |
Controlled Postoperative Blood Glucose (SCIP-4) is one of several additional
surgical infection prevention related measures for hospitals to voluntarily
submit to be eligible for the Annual Payment Update in 2008. This article (click
here) is the first addressing these newly added measures, Cardiac Surgery
Patients with Controlled 6 A.M. Postoperative Blood Glucose and shares the
experiences of two Illinois hospitals improvement activities. This information
is important to all administrators, quality and clinical leaders and staff
responsible for or involved in patient care activities.
Controlled Postoperative Blood Glucose
The Institute for Healthcare Improvement reports that reviews of medical
literature shows that the degree of hyperglycemia in the postoperative period
was correlated with the rate of surgical site infection in patients undergoing
major cardiac surgery. At the same time, advances in endocrinology practices
have allowed for better control of blood glucose levels with the use of IV
insulin protocols. The monitoring and control of patients’ blood glucose is
becoming a more common component of the critical care environment.
Hospitals are encouraged to provide us feedback on this series as well as
contact us to share their success stories and improvement efforts. The articles
from this series are available by clicking here. For
additional information please contact Tim Philipp at
tphilipp@ihastaff.org.
|